INTRODUCTION: Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a costimulatory molecule expressed by activated T cells. This study was performed to investigate the allele and genotype frequencies of CTLA4 gene polymorphisms in Iranian patients with ankylosing spondylitis (AS). METHODS: One hundred and fifty-seven patients with AS and 103 controls were included in this study. Polymorphisms of CTLA4 gene at positions +49 (in exon 1), -318, and -1,147 (in the promoter region) were studied on the genomic DNA using PCR restriction fragment-length polymorphism method. RESULTS: The frequencies of the T allele at position -1147 in the patients with AS was significantly increased in comparison with the control group (11% vs. 5%, P = 0.004); whereas the frequencies of C allele at the same position were significantly decreased in the patient group (89% vs. 95%, P = 0.004). Comparison of genotype frequencies at this position showed that the frequency of CT genotype in comparison with other genotypes was overrepresented in the patient group (20% vs. 8%, P = 0.012), while the CC genotype in comparison with other genotypes was decreased (79% vs. 91%, P = 0.012). There was no significant difference on frequencies of genotypes at the positions -318 and +49. CONCLUSION: This study could suggest an association between specific allele in the promoter region of CTLA4 gene and AS disease.
INTRODUCTION:Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a costimulatory molecule expressed by activated T cells. This study was performed to investigate the allele and genotype frequencies of CTLA4 gene polymorphisms in Iranian patients with ankylosing spondylitis (AS). METHODS: One hundred and fifty-seven patients with AS and 103 controls were included in this study. Polymorphisms of CTLA4 gene at positions +49 (in exon 1), -318, and -1,147 (in the promoter region) were studied on the genomic DNA using PCR restriction fragment-length polymorphism method. RESULTS: The frequencies of the T allele at position -1147 in the patients with AS was significantly increased in comparison with the control group (11% vs. 5%, P = 0.004); whereas the frequencies of C allele at the same position were significantly decreased in the patient group (89% vs. 95%, P = 0.004). Comparison of genotype frequencies at this position showed that the frequency of CT genotype in comparison with other genotypes was overrepresented in the patient group (20% vs. 8%, P = 0.012), while the CC genotype in comparison with other genotypes was decreased (79% vs. 91%, P = 0.012). There was no significant difference on frequencies of genotypes at the positions -318 and +49. CONCLUSION: This study could suggest an association between specific allele in the promoter region of CTLA4 gene and AS disease.
Authors: Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough Journal: Nature Date: 2003-04-30 Impact factor: 49.962
Authors: Segundo Gonzalez; Sonia Garcia-Fernandez; Jesus Martinez-Borra; Miguel Angel Blanco-Gelaz; Luis Rodrigo; Jose Sanchez del Río; Antonio López-Vazquez; Juan Carlos Torre-Alonso; Carlos López-Larrea Journal: Hum Immunol Date: 2002-08 Impact factor: 2.850
Authors: Mohammad Hossein Nicknam; Mahdi Mahmoudi; Ali Akbar Amirzargar; Ahmad Reza Jamshidi; Nima Rezaei; Behrouz Nikbin Journal: Eur Cytokine Netw Date: 2009-03 Impact factor: 2.737
Authors: Tammy M Martin; Louise Bye; Neil Modi; Miles R Stanford; Robert Vaughan; Justine R Smith; N Kevin Wade; Friederike Mackensen; Eric B Suhler; James T Rosenbaum; Graham R Wallace Journal: Mol Vis Date: 2009-01-26 Impact factor: 2.367
Authors: Narjes Soleimanifar; Ali Akbar Amirzargar; Mahdi Mahmoudi; Ali Akbar Pourfathollah; Esfandiar Azizi; Ahmad Reza Jamshidi; Nima Rezaei; Mohammad Taher Tahoori; Katayoon Bidad; Behrouz Nikbin; Mohammad Hossein Nicknam Journal: Inflammation Date: 2011-12 Impact factor: 4.092
Authors: J Karami; M Mahmoudi; A Amirzargar; M Gharshasbi; A Jamshidi; S Aslani; M H Nicknam Journal: Genes Immun Date: 2017-08-10 Impact factor: 2.676
Authors: José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez Journal: Int J Inflam Date: 2013-07-21